PharmaEssentia

Last month, we came together to recognize #BloodCancerAwarenessMonth and celebrate our team’s unwavering commitment to enhancing patient health and quality of life through innovative therapies for hematologic diseases. Thank you for all that you do! #TeamAppreciation

At PharmaEssentia, our world-class expertise and pioneering science drive us to defy the odds in cancer treatment. We believe in the power of collaboration to bring forth novel solutions for those battling hematologic diseases. #BloodCancerAwarenessMonth #BCAM 

Polycythemia vera (PV) symptoms usually develop slowly over many years and are easily overlooked. But early detection is important, as they can become even more severe as the disease progresses. Get the facts about #PV: http://bit.ly/3KlXK47  #BloodCancerAwarenessMonth #BCAM 

We extend our warm wishes to our colleagues celebrating the Mid-Autumn Festival! We hope you enjoy this time spent with friends, family, and loved ones.  

This #BloodCancerAwarenessMonth, we at PharmaEssentia are dedicated to enhancing the lives of those affected by hematologic diseases. Our mission is fueled by innovative therapies and a relentless pursuit of excellence. #BCAM 

Today, we recognize MPN Awareness Day. Awareness of these rare blood cancers leads to understanding, support, and progress. Join us in spreading the word! #BloodCancerAwarenessMonth #BCAM 

This #BloodCancerAwarenessMonth, let's shine a light on rare blood cancers like #PolycythemiaVera (PV) and essential thrombocythemia (ET). Awareness helps to improve early diagnosis and helps everyone with blood cancer feel connected and heard. #BCAM 

Today, we announced that we have entered into an exclusive licensing agreement with FORUS Therapeutics Inc. for the registration and distribution of our #PolycythemiaVera (PV) treatment in Canada. Learn more: https://bit.ly/3AR79hi

Follow along this #BloodCancerAwarenessMonth as we help spread awareness and educate the public about rare blood cancers like #PolycythemiaVera (PV) and essential thrombocythemia (ET).     Learn more about our efforts to offer more treatment pathways: https://bit.ly/3F9hfbx 

Boston Taiwanese Boat Club (BTBC) unites overseas Taiwanese to promote culture and excel in dragon boat racing. On Monday, BTBC will represent the U.S. at the 2024 Club Crew World Championships, competing against 163 clubs — proudly backed by PharmaEssentia. Let's go Titans!